Completed NA INTERVENTIONAL 2-arm NCT00944996

Assessment of Pituitary Adenylate Cyclase Activating Polypeptide-Brain Derived Neurotrophic Factor (PACAP-BDNF) Signaling System Involvement in Etiology and Treatment of Major Depression

Assessment of PACAP-BDNF Signaling System Involvement in Etiology and Treatment of Major Depression

Sponsor: Ariel University

Updated 5 times since 2017 Last updated: Jul 25, 2012 Started: Jun 30, 2009 Primary completion: Jun 30, 2010 Completion: Jul 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00944996, this NA trial focuses on Major Depression and remains completed. Sponsored by Ariel University, it has been updated 5 times since 2009, reflecting limited change activity. Mental health research at this phase helps define safety and dosing parameters for future study.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Jun 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ariel University
The Nazareth Hospital, Israel
Tirat Carmel Mental Health Center
University of Michigan

Data source: Tirat Carmel Mental Health Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Tirat Hacarmel, Israel